Astaxanthin Attenuates Hypertensive Vascular Remodeling by Protecting Vascular Smooth Muscle Cells from Oxidative Stress-Induced Mitochondrial Dysfunction

Abstract

Oxidative stress aggravates mitochondrial injuries and accelerates the proliferation of vascular smooth muscle cells (VSMCs), which are important mechanisms contributing to vascular remodeling in hypertension. We put forward the hypothesis that Astaxanthin (ATX), known to possess strong features of antioxidant, could attenuate vascular remodeling by inhibiting VSMC proliferation and improving mitochondrial function. The potential effects of ATX were tested on spontaneously hypertensive rats (SHRs) and cultured VSMCs that injured by angiotensin II (Ang II). The results showed that ATX lowered blood pressure, reduced aortic wall thickness and fibrosis, and decreased the level of reactive oxygen species (ROS) and H 2 O 2 in tunica media. Moreover, ATX decreased the expression of proliferating cell nuclear antigen (PCNA) and ki67 in aortic VSMCs. In vitro, ATX mitigated VSMC proliferation and migration, decreased the level of cellular ROS, and balanced the activities of ROSrelated enzymes including NADPH oxidase, xanthine oxidase, and superoxide dismutase (SOD). Besides, ATX mitigated Ca 2+ overload, the overproduction of mitochondrial ROS (mtROS), mitochondrial dysfunction, mitochondrial fission, and Drp1 phosphorylation at Ser616. In addition, ATX enhanced mitophagy and mitochondrial biosynthesis by increasing the expression of PINK, parkin, mtDNA, mitochondrial transcription factor A (Tfam), and PGC-1α. The present study indicated that ATX could efficiently treat vascular remodeling through restraining VSMC proliferation and restoring mitochondrial function. Inhibiting mitochondrial fission by decreasing the phosphorylation of Drp1 and stimulating mitochondrial autophagy and biosynthesis via increasing the expression of PINK, parkin, Tfam, and PGC-1α may be part of its underlying mechanisms.

HIF-1-induced mitochondrial ribosome protein L52: a mechanism for breast cancer cellular adaptation and metastatic initiation in response to hypoxia

“…At normal cellular levels, ROS regulate a wide range of cellular responses, including growth, differentiation, ageing, transcription factor activity, and inflammatory reactions 41 - 47 . Nevertheless, abnormal generation of ROS has been discovered to be involved in various diseases, such as cancer, cardiovascular disease, diabetes and skin disorders 45 , 48 - 52 . Deficiency of O 2 in the tumor microenvironment is one of the principal causes of ROS overproduction in cancer cells.…”

Mini-Revisão Sobre Os Carotenoides: Conceitos, Fontes E Atividades Biológicas

“…Pigmentos encontrados na maioria das frutas e vegetais, plantas, algas e bactérias resistência a insulina (NI et al, 2015), proteção do músculo liso vascular (CHEN et al, 2020), agente neuroprotetor contra a isquemia do nervo óptico (LIN et al, 2020), homeostase mitocondrial do cálcio (SZTRETYE et al, 2020), prevenção da osteoartrite (SUN et al, 2019), antioxidante e anti-envelhecimento (EREN et al, 2019), proliferação e migração de células cancerosas da mama in vitro (McCall et al, 2018), pigmentação do leite (MEZQUITA et al, 2015), tratamento da dermatite de contato (KIM et al, 2015), supressão de enfisema pulmonar (KUBO et al, 2019), proteção contra danos à retina (OTSUKA et al, 2016), prevenção de lesão pulmonar (CAI et al, 2019), além do uso como aditivos em cosméticos (TOMINAGA et al, 2012).…”

Antioxidant and anti‑inflammatory mechanisms of action of astaxanthin in cardiovascular diseases (Review)

“…Chen et al (2020) reported that this carotenoid also participated in the remodeling of the smooth muscle cells of the vessels, reducing their proliferation and the damage caused by oxidative stress. Astaxanthin lowered RONS levels by increasing the activity of antioxidant enzymes and regulating mitochondrial dynamics, mitophagy and mitochondrial biogenesis, which are important for the maintenance of mitochondrial and cellular metabolism ( 39 ).…”